Please login to the form below
How to deal with HCPs’ change in preferences after the pandemic
By Darren Talbot (pictured right) and Dirk Szynka (pictured left)
Antimicrobial resistance – the silent pandemic
By Isabella Talbot
Who needs to be trusted anyway?
By Luke Cripps
How diversity and inclusion continues to be incorporated in dermatology
*This article has been developed and funded by Janssen-Cilag Ltd
-
Looking to the future of patient empowermentBy Max Noble
-
Creating patient support programmes that help patients thriveBy Laura Meade
-
Patient support programmes: providing meaningful care when you dare to treat rareBy Aaron Hall
-
The value of patient reported outcomesBy Su Smith
-
The benefits of patient support programmes in specific disease areasBy Charlotte Maule
-
Collaboration over complacency in reshaping the future of cardiovascular careInterview with Oliver Appelhans
Subscribe to our email news alerts
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS presents positive four-year results for Opdivo combination in lung cancer
- Pfizer reports positive results for elranatamab in multiple myeloma
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- Pfizer’s RSV vaccine approved by FDA for older adults
- AstraZeneca to stop post-marketing study of Andexxa following early success
- Janssen shares positive phase 3 results for erdafitinib in bladder cancer
- Generative AI is coming for healthcare
- Merck sues US government over Medicare drug price negotiation programme
- GSK’s RSV vaccine approved by European Commission for older adults
- The 17th World Congress on Controversies in Neurology
No results were found
PMHub
Collected Group
Collected Group is a forward thinking healthcare communication company that supports biopharma and diagnostic companies to engage in more lasting...
Latest intelligence
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
